These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 194385)

  • 1. Vaccination of pregnant sows with Clostridium perfringens type C toxoid.
    Kennedy KK; Norris SJ; Beckenhauer WH; Hogg A
    Vet Med Small Anim Clin; 1977 Jun; 72(6):1047-9. PubMed ID: 194385
    [No Abstract]   [Full Text] [Related]  

  • 2. Antitoxin titer in colostrum and milk after vaccination of sows with Clostridium perfringens type C toxoid vaccine.
    Djurickovic SM; Dworak JE; Wickham KL
    Vet Med Small Anim Clin; 1975 Mar; 70(3):283-5. PubMed ID: 164076
    [No Abstract]   [Full Text] [Related]  

  • 3. Antitoxin response in cattle vaccinated with Clostridium perfringens type C toxoid.
    Kennedy KK; Norris SJ; Beckenhauer WH; White RG
    Vet Med Small Anim Clin; 1977 Jul; 72(7):1213-5. PubMed ID: 196381
    [No Abstract]   [Full Text] [Related]  

  • 4. Vaccination of cattle and sheep with a combined Clostridium perfringens types C and D toxoid.
    Kennedy KK; Norris SJ; Beckenhauer WH; White RG
    Am J Vet Res; 1977 Oct; 38(10):1515-7. PubMed ID: 201186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colostral transfer of Clostridium perfringens type C beta antitoxin in swine.
    Matisheck PH; McGinley M
    Am J Vet Res; 1986 May; 47(5):1132-3. PubMed ID: 2872843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The detection of the factor lowering the immunogenicity of toxoid of Clostridium perfringens type A.
    Shemanova GF; Vlasova EV; Sergeeva TI; Panteleyev EI
    Arch Roum Pathol Exp Microbiol; 1981; 40(4):299-303. PubMed ID: 6280638
    [No Abstract]   [Full Text] [Related]  

  • 7. Prevention of necrotic enteritis in piglets by vaccination of pregnant gilts with a Clostridium perfringens type C and D bacterin-toxoid.
    Kelnerić Z; Naglić T; Udovicić I
    Vet Med (Praha); 1996 Nov; 41(11):335-8. PubMed ID: 9036619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative study on the immunogenic properties of Clostridium perfringens type A toxoid.
    Shemanova GF; Vlasova EV; Dmitrieva LN; Trapezov EV; Gorbacheva LD
    J Hyg Epidemiol Microbiol Immunol; 1986; 30(3):323-9. PubMed ID: 2877025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Studies of necrotizing enteritis of suckling piglets (Clostridium perfringens type C enterotoxemia) in industrialized sow breeding units. 5. Control of the disease].
    Köhler B; Zabke J; Reiher K; Rummler HJ
    Arch Exp Veterinarmed; 1979; 33(4):621-37. PubMed ID: 232841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathogenesis and immunity of Clostridium perfringens type C enteritis in swine.
    Bergeland ME
    J Am Vet Med Assoc; 1972 Feb; 160(4):568-71. PubMed ID: 4337842
    [No Abstract]   [Full Text] [Related]  

  • 11. The prevention of experimental Clostridium novyi and Cl. perfringens gas gangrene in high-velocity missile wounds by active immunisation.
    Boyd NA; Thomson RO; Walker PD
    J Med Microbiol; 1972 Nov; 5(4):467-72. PubMed ID: 4345766
    [No Abstract]   [Full Text] [Related]  

  • 12. Experimental studies on serum treatment and vaccination against Cl. perfringens type C infection in piglets.
    Hogh P
    Dev Biol Stand; 1976; 32():69-76. PubMed ID: 187513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enterotoxemia in the goat: the humoral response and local tissue reaction following vaccination with two different bacterin-toxoids.
    Blackwell TE; Butler DG; Bell JA
    Can J Comp Med; 1983 Apr; 47(2):127-32. PubMed ID: 6309346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. E. coli heat-labile (LT) antitoxin levels in pigs and in E. coli-vaccinated sows.
    Pesti L; Semjén G
    Acta Vet Acad Sci Hung; 1980; 28(1):13-20. PubMed ID: 7018204
    [No Abstract]   [Full Text] [Related]  

  • 15. [Factors modulating production of antibodies against Clostridium perfringens in mammals].
    Shemanova GF; Sergeeva TI; Panteleev EI; Vlasova EV; Dmitrieva LN
    Biull Eksp Biol Med; 1981 Sep; 92(9):322-5. PubMed ID: 6271303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Production and characterization of Clostridium perfringens recombinant β toxoid.
    Milach A; de los Santos JR; Turnes CG; Moreira AN; de Assis RA; Salvarani FM; Lobato FC; Conceição FR
    Anaerobe; 2012 Jun; 18(3):363-5. PubMed ID: 22306065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenicity of highly purified -toxoid of Clostridium perfringens.
    Sato H; Kameyama S; Murata R
    Jpn J Med Sci Biol; 1972 Feb; 25(1):53-6. PubMed ID: 4338981
    [No Abstract]   [Full Text] [Related]  

  • 18. The prevention of pig-bel in Papua New Guinea.
    Lawrence G; Walker PD; Freestone DS; Shann F
    P N G Med J; 1979 Mar; 22(1):30-4. PubMed ID: 233174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development, preparation and safety testing of a Clostridium welchii type C toxoid. I: preliminary observations in man in Papua New Guinea.
    Walker PD; Foster WH; Knight PA; Freestone DS; Lawrence G
    J Biol Stand; 1979; 7(4):315-23. PubMed ID: 231605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immunogenicity and thymus-dependence of the polymerized alpha-toxoid of Clostridium perfringens].
    Petrov RV; Shemanova GF; Kaverzneva ED; Kissel' VL; Panteleev EI
    Biull Eksp Biol Med; 1977 Dec; 84(12):695-8. PubMed ID: 202354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.